Energy intake in patients with HIV infection, SBD, and postsurgical patients, either with IPAA or SBS
| p Value | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| HIV v surgical | HIV v SBD | SBD v surgical | |||||||
| Lipid malabsorption 0–5% | HIV (n=13) | IPAA (n=10) | SBD (n=9) | ||||||
| BMI | 19.6 (14.7–22.6) | 22.5 (16.8–27.0) | 17.0 (12.7–26.5) | 0.01 | NS | 0.005 | |||
| Energy intake (kJ/kg IBW/d) | 92 (54–151) | 130 (88–163) | 159 (96–184) | 0.02 | < 0.001 | < 0.2 | |||
| Lipid malabsorption 6–20% | HIV (n=34) | SBS (n=22) | SBD (n=16) | ||||||
| BMI | 19.1 (14.0–23.0) | 19.8 (16.4–27.3) | 19.7 (13.0–24.0) | 0.05 | < 0.10 | NS | |||
| Energy intake (kJ/kg IBW/d) | 100 (42–151) | 125 (67–159) | 125 (75–238) | < 0.001 | < 0.002 | NS | |||
| Lipid malabsorption > 20% | HIV (n=32) | SBS (n=53) | SBD (n=13) | ||||||
| BMI | 19.0 (12.9–28) | 19.6 (12.9–28) | 18.1 (13.2–24.2) | < 0.10 | NS | < 0.05 | |||
| Energy intake (kJ/kg IBW/d) | 92 (38–167) | 134 (67–301) | 113 (59–155) | < 0.001 | < 0.005 | < 0.005 | |||
IBW, ideal body weight.